Select for export Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2022-08-31 Rodrigues J, Nombora O, Ribeiro L. Europe PMC Published psilocybin OCDMechanism of ActionReceptor Pharmacology Systematic Review More
Select for export Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2022-08-31 Girala N. Europe PMC Published psilocybin DepressionAddictionEmotional Processing Review Article More
Select for export A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2022-08-31 Chue P, Andreiev A, Bucuci E, Els C, Chue J. Europe PMC Published psilocybinpsilocin PharmacologyReceptor PharmacologyEpigenetics Review Article More
Select for export [The use of psilocybin for treatment-resistant depression]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17992/lbl.2022.09.706 PubMed 36040772 Copy citation Copy BibTeX Unknown journal 2022-08-31 Johannesdottir A, Sigurdsson E. Europe PMC Published psilocybin DepressionHeadache / MigraineMechanism of Action Randomized Controlled Trial More
Select for export To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000597 PubMed 36048112 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2022-08-31 Christensen JA, Fipps DC, Bostwick JM. Europe PMC Published psilocybin AddictionBrain ImagingReview Article Review Article More
Select for export Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221116926 PubMed 36017784 Copy citation Copy BibTeX Unknown journal 2022-08-25 Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Europe PMC Published psilocybin AnxietyHeadache / MigraineClinical Trial Systematic Review More
Select for export ‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64336/001c.37945 Copy citation Copy BibTeX Journal of High School Science 2022-08-23 Graham Zoe Crossref Published psilocybin DepressionReceptor PharmacologyReview Article Review Article More
Select for export Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/anoc.12154 Copy citation Copy BibTeX Anthropology of Consciousness 2022-08-21 Neşe Devenot, Trey Conner, Richard Doyle OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109214 PubMed 35973601 Copy citation Copy BibTeX Unknown journal 2022-08-12 Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS Europe PMC Published psilocybin Review Article Review Article More
Select for export Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01361-0 PubMed 35953638 Copy citation Copy BibTeX Unknown journal 2022-08-11 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Europe PMC Published psilocybin DepressionEnd-of-Life DistressMechanism of Action Clinical Trial More
Select for export Med Check: Psilocybin for OCD, Nuplazid Vote, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.08.8.2 Copy citation Copy BibTeX Psychiatric News 2022-07-31 Terri D’Arrigo OpenAlex Published psilocybin DepressionOCDHeadache / Migraine Clinical Trial More
Select for export The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2022.104706 PubMed 35609684 Copy citation Copy BibTeX Neuroscience and biobehavioral reviews 2022-07-31 Polito V, Liknaitzky P PubMed Published psilocybin Chronic PainConsciousnessMicrodosing Systematic Review More
Select for export Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.917199 PubMed 35923458 Copy citation Copy BibTeX Unknown journal 2022-07-11 Ko K, Knight G, Rucker JJ, Cleare AJ. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852922000888 PubMed 35811423 Copy citation Copy BibTeX Unknown journal 2022-07-10 Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Review Article More
Select for export Psychedelics in the treatment of unipolar and bipolar depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40345-022-00265-5 PubMed 35788817 Copy citation Copy BibTeX Unknown journal 2022-07-04 Bosch OG, Halm S, Seifritz E. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2022.104689 PubMed 35588933 Copy citation Copy BibTeX Neuroscience and biobehavioral reviews 2022-06-30 McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE PubMed Published psilocybinpsilocin Brain ImagingMechanism of ActionReceptor Pharmacology Review Article More
Select for export Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-06-29 Wake Network, Inc. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.927984 PubMed 35837277 Copy citation Copy BibTeX Unknown journal 2022-06-27 Vorobyeva N, Kozlova AA. Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.26402 PubMed 35915689 Copy citation Copy BibTeX Unknown journal 2022-06-27 Inouye A, Wolfgang A. Europe PMC Published psilocybin DepressionPTSDClinical Trial Clinical Trial More
